Skip to main content
. 2026 Apr 1;14(7):910. doi: 10.3390/healthcare14070910
VTE Venous thromboembolism
NSCLC Non-small-cell lung cancer
ISTH International Society for Thrombosis and Hemostasis
ASCO American Society of Clinical Oncology
KMO Kaiser–Meyer–Olkin
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
LMWH Low molecular weight heparin
DOACs Direct oral anticoagulants
AVERT Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients trial
CASSINI Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial